@AnnetteReichel We have SEEN FIPA's effect for the past decade and change. 1. An EFFECTIVE TB vaccine scuppered by CanSino https://t.co/El5N7eXaj4 2. Forced to buy tomatoes from concentration camps https://t.co/4zWOiulfLz 3. Forced to print Sinovac prop
in combination with this VERY sus paper from CMAJ (yah SinoVac doesn't do that, not at all), which at least proves the efficacy of Pfizer (pre-bivalent) against dying the death odds down to about 10% (if you want to play that game of Russian roulette)... h
@MJSJ_YT @HomerGlumplich @MoriartyLab Do you know WHY the vaccines are "only" 90% effective AGAINST DEATH if you have comorbidities? https://t.co/iEY9LXlio5 Because plague rats were encouraged by #disinformation campaigns on #Twitter to spread #COVID19 unt
@AwakeVoting @Lukafoto @AlastairMcA30 @Johnincarlisle CMAJ study shows 90% protection against death for people with 2 or more comorbidities with mRNA booster. The bit about the inactivated vaccine having the same profile is #Chinese #propaganda (lies) CMAJ
My other favourite (what the paper says about CoronaVac is BS, that IS #Chinese #propaganda): "Among people with multimorbidity, booster vaccination with BNT162b2...was associated with reductions of more than 90% in COVID-19–related mortality rates" 90%!!
Oh yah this one was DEFINITELY #censored via "automatic" processes triggered by false reports bombing it - can you guess why?! Hint: Read the thread.
@DejaCoup @BadVaccineTakes May I quote you one of my favourite sentences from a recent research paper? "Among people with multimorbidity, #booster #vaccination with BNT162b2[#Pfizer] ... was associated with reductions of >more than 90%< in COVID-19
@BeckerBalluff @ThomasHelmut8 @kutschera_u Als Studienrat und Autor zeigen Sie aber ganz schön viel Unwissen. Aber ich helfe ihnen gerne das zu ändern. Zur Übertragung empfehle ich diese Studien zu lesen. https://t.co/JPMs4ZACUu Wie gut sie gerade in ihre
@kutschera_u @Markus_A81 https://t.co/hUEXVaiYQd Alte Menschen sind übrigens oft von Multimorbität betroffen.😉 https://t.co/zhanONQSWU
RT @hancocktom: Hong Kong study from earlier this year finding that sinovac and biontech booster shots offered similar levels of protection…
元論文は Canadian Medical Association Journal 「不活化全ウイルスまたはmRNAワクチンによる追加接種と、多疾患併存者におけるCOVID-19関連死亡:コホート研究」 https://t.co/W7EqaeSd0y https://t.co/QgA4REEQqS
@whykeepitup This one's better - yes, it's sus, because the data about Sinovac is bullshit, but what's hilarious is even the Chinese know they can't dip on Pfizer without losing all credibility, so they tried to say theirs was as effective as Pfizer, inste
RT @FranciscoTTLai1: Our @HkuPharm @hkumed team's latest paper in @CMAJ shows >90% reduction of #COVID19-related deaths among people with #…
En un estudio reciente publicado en Canadian Medical Association Journal se describe las ventajas del uso de las vacunas de refuerzo contra COVID-19. https://t.co/b2Jbvp7rOK https://t.co/1sfbKqiVcE
RT @ghvillain1: 부스터 백신(3회, 시노박/화이자)을 맞은 만성복합질환자들의 코로나19 관련 사망률이 코로나 백신 접종을 2회만 한 사람들에 비해 90% 감소했다는 홍콩의 연구결과. https://t.co/hlc1n0s4Nx
RT @ghvillain1: 부스터 백신(3회, 시노박/화이자)을 맞은 만성복합질환자들의 코로나19 관련 사망률이 코로나 백신 접종을 2회만 한 사람들에 비해 90% 감소했다는 홍콩의 연구결과. https://t.co/hlc1n0s4Nx
RT @ghvillain1: 부스터 백신(3회, 시노박/화이자)을 맞은 만성복합질환자들의 코로나19 관련 사망률이 코로나 백신 접종을 2회만 한 사람들에 비해 90% 감소했다는 홍콩의 연구결과. https://t.co/hlc1n0s4Nx
RT @ghvillain1: 부스터 백신(3회, 시노박/화이자)을 맞은 만성복합질환자들의 코로나19 관련 사망률이 코로나 백신 접종을 2회만 한 사람들에 비해 90% 감소했다는 홍콩의 연구결과. https://t.co/hlc1n0s4Nx
RT @ghvillain1: 부스터 백신(3회, 시노박/화이자)을 맞은 만성복합질환자들의 코로나19 관련 사망률이 코로나 백신 접종을 2회만 한 사람들에 비해 90% 감소했다는 홍콩의 연구결과. https://t.co/hlc1n0s4Nx
RT @ghvillain1: 부스터 백신(3회, 시노박/화이자)을 맞은 만성복합질환자들의 코로나19 관련 사망률이 코로나 백신 접종을 2회만 한 사람들에 비해 90% 감소했다는 홍콩의 연구결과. https://t.co/hlc1n0s4Nx
RT @ghvillain1: 부스터 백신(3회, 시노박/화이자)을 맞은 만성복합질환자들의 코로나19 관련 사망률이 코로나 백신 접종을 2회만 한 사람들에 비해 90% 감소했다는 홍콩의 연구결과. https://t.co/hlc1n0s4Nx
RT @ghvillain1: 부스터 백신(3회, 시노박/화이자)을 맞은 만성복합질환자들의 코로나19 관련 사망률이 코로나 백신 접종을 2회만 한 사람들에 비해 90% 감소했다는 홍콩의 연구결과. https://t.co/hlc1n0s4Nx
RT @ghvillain1: 부스터 백신(3회, 시노박/화이자)을 맞은 만성복합질환자들의 코로나19 관련 사망률이 코로나 백신 접종을 2회만 한 사람들에 비해 90% 감소했다는 홍콩의 연구결과. https://t.co/hlc1n0s4Nx
RT @ghvillain1: 부스터 백신(3회, 시노박/화이자)을 맞은 만성복합질환자들의 코로나19 관련 사망률이 코로나 백신 접종을 2회만 한 사람들에 비해 90% 감소했다는 홍콩의 연구결과. https://t.co/hlc1n0s4Nx
RT @oldnick53: Booster vaccination with inactivated whole-virus or mRNA vaccines and COVID-19–related deaths among people with multimorbidi…
RT @ghvillain1: 부스터 백신(3회, 시노박/화이자)을 맞은 만성복합질환자들의 코로나19 관련 사망률이 코로나 백신 접종을 2회만 한 사람들에 비해 90% 감소했다는 홍콩의 연구결과. https://t.co/hlc1n0s4Nx
RT @ghvillain1: 부스터 백신(3회, 시노박/화이자)을 맞은 만성복합질환자들의 코로나19 관련 사망률이 코로나 백신 접종을 2회만 한 사람들에 비해 90% 감소했다는 홍콩의 연구결과. https://t.co/hlc1n0s4Nx
RT @kamleshkhunti: Among people with multimorbidity, booster #CovidVaccination associated > 90% reductions in #COVID19 related mortality r…
RT @kamleshkhunti: Among people with multimorbidity, booster #CovidVaccination associated > 90% reductions in #COVID19 related mortality r…
Among people with multimorbidity, booster #CovidVaccination associated > 90% reductions in #COVID19 related mortality rates compared with only 2 doses. #GetVaccinated https://t.co/vGrTHKLsZ0 https://t.co/CjyI1QhGig
Perspective on recent double-vaxxed study; do boosters⬇️mortality with Omicron for people with multiple co-morbidities https://t.co/oGsoxZjL16 Here’s what they found👇
RT @ghvillain1: 부스터 백신(3회, 시노박/화이자)을 맞은 만성복합질환자들의 코로나19 관련 사망률이 코로나 백신 접종을 2회만 한 사람들에 비해 90% 감소했다는 홍콩의 연구결과. https://t.co/hlc1n0s4Nx
RT @ghvillain1: 부스터 백신(3회, 시노박/화이자)을 맞은 만성복합질환자들의 코로나19 관련 사망률이 코로나 백신 접종을 2회만 한 사람들에 비해 90% 감소했다는 홍콩의 연구결과. https://t.co/hlc1n0s4Nx
RT @ghvillain1: 부스터 백신(3회, 시노박/화이자)을 맞은 만성복합질환자들의 코로나19 관련 사망률이 코로나 백신 접종을 2회만 한 사람들에 비해 90% 감소했다는 홍콩의 연구결과. https://t.co/hlc1n0s4Nx
RT @ghvillain1: 부스터 백신(3회, 시노박/화이자)을 맞은 만성복합질환자들의 코로나19 관련 사망률이 코로나 백신 접종을 2회만 한 사람들에 비해 90% 감소했다는 홍콩의 연구결과. https://t.co/hlc1n0s4Nx
RT @ghvillain1: 부스터 백신(3회, 시노박/화이자)을 맞은 만성복합질환자들의 코로나19 관련 사망률이 코로나 백신 접종을 2회만 한 사람들에 비해 90% 감소했다는 홍콩의 연구결과. https://t.co/hlc1n0s4Nx
RT @ghvillain1: 부스터 백신(3회, 시노박/화이자)을 맞은 만성복합질환자들의 코로나19 관련 사망률이 코로나 백신 접종을 2회만 한 사람들에 비해 90% 감소했다는 홍콩의 연구결과. https://t.co/hlc1n0s4Nx
RT @ghvillain1: 부스터 백신(3회, 시노박/화이자)을 맞은 만성복합질환자들의 코로나19 관련 사망률이 코로나 백신 접종을 2회만 한 사람들에 비해 90% 감소했다는 홍콩의 연구결과. https://t.co/hlc1n0s4Nx
RT @ghvillain1: 부스터 백신(3회, 시노박/화이자)을 맞은 만성복합질환자들의 코로나19 관련 사망률이 코로나 백신 접종을 2회만 한 사람들에 비해 90% 감소했다는 홍콩의 연구결과. https://t.co/hlc1n0s4Nx
RT @ghvillain1: 부스터 백신(3회, 시노박/화이자)을 맞은 만성복합질환자들의 코로나19 관련 사망률이 코로나 백신 접종을 2회만 한 사람들에 비해 90% 감소했다는 홍콩의 연구결과. https://t.co/hlc1n0s4Nx
RT @ghvillain1: 부스터 백신(3회, 시노박/화이자)을 맞은 만성복합질환자들의 코로나19 관련 사망률이 코로나 백신 접종을 2회만 한 사람들에 비해 90% 감소했다는 홍콩의 연구결과. https://t.co/hlc1n0s4Nx
RT @ghvillain1: 부스터 백신(3회, 시노박/화이자)을 맞은 만성복합질환자들의 코로나19 관련 사망률이 코로나 백신 접종을 2회만 한 사람들에 비해 90% 감소했다는 홍콩의 연구결과. https://t.co/hlc1n0s4Nx
RT @ghvillain1: 부스터 백신(3회, 시노박/화이자)을 맞은 만성복합질환자들의 코로나19 관련 사망률이 코로나 백신 접종을 2회만 한 사람들에 비해 90% 감소했다는 홍콩의 연구결과. https://t.co/hlc1n0s4Nx
RT @oldnick53: Booster vaccination with inactivated whole-virus or mRNA vaccines and COVID-19–related deaths among people with multimorbidi…
RT @oldnick53: Booster vaccination with inactivated whole-virus or mRNA vaccines and COVID-19–related deaths among people with multimorbidi…
RT @oldnick53: Booster vaccination with inactivated whole-virus or mRNA vaccines and COVID-19–related deaths among people with multimorbidi…
RT @dokhollidays: ‼️Neue Kohortenstudie zeigt: Boosterimpfung (sowohl BNTX als auch Sinovac) reduziert das Risiko für Tod durch Covid19 ins…
RT @gbiondizoccai: Vaccines are the greatest medical invention ever! Indeed, in this in Hong Kong cohort study, 'among people with multimor…
Vaccines are the greatest medical invention ever! Indeed, in this in Hong Kong cohort study, 'among people with multimorbidity, booster vaccination was associated with >90% reductions in COVID-19–related mortality rates compared with only 2 doses' https
RT @dokhollidays: ‼️Neue Kohortenstudie zeigt: Boosterimpfung (sowohl BNTX als auch Sinovac) reduziert das Risiko für Tod durch Covid19 ins…
Jos kuulut covid-riskiryhmiin, kannattaa ottaa kolmas rokoteannos, jos et ole vielä ottanut. Tuore julkaisu: https://t.co/yTmxO5vOGQ
RT @dokhollidays: ‼️Neue Kohortenstudie zeigt: Boosterimpfung (sowohl BNTX als auch Sinovac) reduziert das Risiko für Tod durch Covid19 ins…
RT @dokhollidays: ‼️Neue Kohortenstudie zeigt: Boosterimpfung (sowohl BNTX als auch Sinovac) reduziert das Risiko für Tod durch Covid19 ins…
RT @EstebanOrtizMD: Un régimen de tres dosis de la vacuna COVID-19, en comparación con dos dosis, se asocia con una disminución superior al…
RT @EstebanOrtizMD: Un régimen de tres dosis de la vacuna COVID-19, en comparación con dos dosis, se asocia con una disminución superior al…
RT @EstebanOrtizMD: Un régimen de tres dosis de la vacuna COVID-19, en comparación con dos dosis, se asocia con una disminución superior al…
Un régimen de tres dosis de la vacuna COVID-19, en comparación con dos dosis, se asocia con una disminución superior al 90% de las muertes relacionadas con COVID-19 entre pacientes con múltiples enfermedades crónicas, según sugieren los datos https://t.co
...Among people with multimorbidity, booster vaccination with BNT162b2 or CoronaVac was associated with reductions of more than 90% in COVID-19–related mortality rates compared with only 2 doses. https://t.co/gpW3B0glF7
RT @dokhollidays: ‼️Neue Kohortenstudie zeigt: Boosterimpfung (sowohl BNTX als auch Sinovac) reduziert das Risiko für Tod durch Covid19 ins…
RT @dokhollidays: ‼️Neue Kohortenstudie zeigt: Boosterimpfung (sowohl BNTX als auch Sinovac) reduziert das Risiko für Tod durch Covid19 ins…
RT @dokhollidays: ‼️Neue Kohortenstudie zeigt: Boosterimpfung (sowohl BNTX als auch Sinovac) reduziert das Risiko für Tod durch Covid19 ins…
“Interpretation: Among people with multimorbidity, booster vaccination with BNT162b2 or CoronaVac was associated with reductions of more than 90% in COVID-19–related mortality rates compared with only 2 doses.” https://t.co/TrRrbci4nI
RT @dokhollidays: ‼️Neue Kohortenstudie zeigt: Boosterimpfung (sowohl BNTX als auch Sinovac) reduziert das Risiko für Tod durch Covid19 ins…
RT @dokhollidays: ‼️Neue Kohortenstudie zeigt: Boosterimpfung (sowohl BNTX als auch Sinovac) reduziert das Risiko für Tod durch Covid19 ins…
RT @dokhollidays: ‼️Neue Kohortenstudie zeigt: Boosterimpfung (sowohl BNTX als auch Sinovac) reduziert das Risiko für Tod durch Covid19 ins…
RT @dokhollidays: ‼️Neue Kohortenstudie zeigt: Boosterimpfung (sowohl BNTX als auch Sinovac) reduziert das Risiko für Tod durch Covid19 ins…
RT @dokhollidays: ‼️Neue Kohortenstudie zeigt: Boosterimpfung (sowohl BNTX als auch Sinovac) reduziert das Risiko für Tod durch Covid19 ins…
RT @dokhollidays: ‼️Neue Kohortenstudie zeigt: Boosterimpfung (sowohl BNTX als auch Sinovac) reduziert das Risiko für Tod durch Covid19 ins…
RT @dokhollidays: ‼️Neue Kohortenstudie zeigt: Boosterimpfung (sowohl BNTX als auch Sinovac) reduziert das Risiko für Tod durch Covid19 ins…
‼️Neue Kohortenstudie zeigt: Boosterimpfung (sowohl BNTX als auch Sinovac) reduziert das Risiko für Tod durch Covid19 insbesondere bei multimorbiden Älteren um >90%. Diese Studie beweist erneut eindrucksvoll wie wichtig Booster für kranke Ältere sind!
“A regime of three doses of COVID-19 vaccine, compared with two doses, is associated with a greater than 90% decrease in COVID-19-related deaths among patients with multiple chronic conditions, data suggest.” https://t.co/kI46s4A4IV
RT @morilyn1123: 香港のmRNA、不活化(シノバック)ワクチンのブースター接種の死亡予防効果を見た研究。対象は複数のハイリスク因子を持つ高齢者を中心としたグループ。シノバックは3回接種すると有効率高い。これでもシノバックはファイザーの4倍くらい悪いのですが、十分…
RT @TaNaishaJ: 4/4 "These results highlight the crucial role of #booster #vaccination for protecting #vulnerable #populations as the #COVID…
RT @TaNaishaJ: 4/4 "These results highlight the crucial role of #booster #vaccination for protecting #vulnerable #populations as the #COVID…
RT @morilyn1123: 香港のmRNA、不活化(シノバック)ワクチンのブースター接種の死亡予防効果を見た研究。対象は複数のハイリスク因子を持つ高齢者を中心としたグループ。シノバックは3回接種すると有効率高い。これでもシノバックはファイザーの4倍くらい悪いのですが、十分…
4/4 "These results highlight the crucial role of #booster #vaccination for protecting #vulnerable #populations as the #COVID-19 #pandemic continues to evolve." #COVID19 #CovidIsNotOver #SARSCoV2 https://t.co/q7OWaZCx4S
コロナ 不活化ワクチン シノバック
RT @morilyn1123: 香港のmRNA、不活化(シノバック)ワクチンのブースター接種の死亡予防効果を見た研究。対象は複数のハイリスク因子を持つ高齢者を中心としたグループ。シノバックは3回接種すると有効率高い。これでもシノバックはファイザーの4倍くらい悪いのですが、十分…
RT @morilyn1123: 香港のmRNA、不活化(シノバック)ワクチンのブースター接種の死亡予防効果を見た研究。対象は複数のハイリスク因子を持つ高齢者を中心としたグループ。シノバックは3回接種すると有効率高い。これでもシノバックはファイザーの4倍くらい悪いのですが、十分…
RT @morilyn1123: 香港のmRNA、不活化(シノバック)ワクチンのブースター接種の死亡予防効果を見た研究。対象は複数のハイリスク因子を持つ高齢者を中心としたグループ。シノバックは3回接種すると有効率高い。これでもシノバックはファイザーの4倍くらい悪いのですが、十分…
RT @morilyn1123: 香港のmRNA、不活化(シノバック)ワクチンのブースター接種の死亡予防効果を見た研究。対象は複数のハイリスク因子を持つ高齢者を中心としたグループ。シノバックは3回接種すると有効率高い。これでもシノバックはファイザーの4倍くらい悪いのですが、十分…
RT @morilyn1123: 香港のmRNA、不活化(シノバック)ワクチンのブースター接種の死亡予防効果を見た研究。対象は複数のハイリスク因子を持つ高齢者を中心としたグループ。シノバックは3回接種すると有効率高い。これでもシノバックはファイザーの4倍くらい悪いのですが、十分…
RT @morilyn1123: 香港のmRNA、不活化(シノバック)ワクチンのブースター接種の死亡予防効果を見た研究。対象は複数のハイリスク因子を持つ高齢者を中心としたグループ。シノバックは3回接種すると有効率高い。これでもシノバックはファイザーの4倍くらい悪いのですが、十分…
RT @morilyn1123: 香港のmRNA、不活化(シノバック)ワクチンのブースター接種の死亡予防効果を見た研究。対象は複数のハイリスク因子を持つ高齢者を中心としたグループ。シノバックは3回接種すると有効率高い。これでもシノバックはファイザーの4倍くらい悪いのですが、十分…
香港のmRNA、不活化(シノバック)ワクチンのブースター接種の死亡予防効果を見た研究。対象は複数のハイリスク因子を持つ高齢者を中心としたグループ。シノバックは3回接種すると有効率高い。これでもシノバックはファイザーの4倍くらい悪いのですが、十分な効果だと思います。 https://t.co/xa2UHeaCZi https://t.co/2g6l7SssO4
An article published in @CMAJ titled ‘Booster vaccination with inactivated whole-virus or mRNA vaccines and COVID-19–related deaths among people with multimorbidity: a cohort study’ is now available. Access it here: https://t.co/tcUdSJZCl5. #COVID19 #Vac
@Ian_HKU and @Esther_CSMPRHKU of the @HKU_D24H and their team published a paper in @CMAJ shows >90% reduction of #COVID19-related deaths among people with #multimorbidity after a #booster shot of BNT162b2 or CoronaVac @hkumed @HKU_SPH https://t.co/rDCMK
https://t.co/dbf9oFFjRs Estudio 👉 Vacunación de refuerzo con vacunas inactivadas de virus completo o ARNm y muertes relacionadas con COVID-19 entre personas con multimorbilidad: un estudio de cohorte
RT @BagaiDr: Booster vac with inactiv whole-virus or mRNA vac & COVID19–death with multimorbidity: BNT162b2, booster-vac⬇️COVID19–death vs…
Booster vac with inactiv whole-virus or mRNA vac & COVID19–death with multimorbidity: BNT162b2, booster-vac⬇️COVID19–death vs 2vax (5 v. 34, IR 1.3 v. 23.4 per million person-days,[IRR] 0.05.;CoronaVac booster vac vs 2Vac(26 v. 88, IR 5.3 v. 53.1, IRR
CoronaVac 2 dose: 88/32341 0.27% 3 dose: 0.027% NNT: 411 (NNT refers to number of people who need the intervention for one person to benefit. The less the NNT, the more effective the intervention) Link to study 2/4 https://t.co/kUVd2EljYL
RT @FranciscoTTLai1: Our @HkuPharm @hkumed team's latest paper in @CMAJ shows >90% reduction of #COVID19-related deaths among people with #…